Life ScienceCompany
Janssen Pharmaceuticals M&A Summary
Janssen Pharmaceuticals has acquired 5 companies, including 1 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 3 assets.
Janssen Pharmaceuticals’ largest acquisition to date was in 2019, when it acquired XBiotech - Novel Antibody Bermekimab for $750M. It’s largest disclosed sale occurred in 2011, when it sold Ortho Dermatologics to Bausch Health Companies for $345M. Janssen Pharmaceuticals has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).
Janssen Pharmaceuticals Business Overview
Where is Janssen Pharmaceuticals headquartered?
Janssen Pharmaceuticals is headquartered in Titusville, New Jersey.
What sector is Janssen Pharmaceuticals in?
Janssen Pharmaceuticals is a life science company.
When was Janssen Pharmaceuticals founded?
Janssen Pharmaceuticals was founded in 1973.
M&A Summary
-
M&A Total Activity7
- M&A Buy Activity4
- M&A Sell Activity3
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 7
Unlimited Searches
